Article

A high-throughput 3D culture microfluidic platform for multi-parameter phenotypic and omics profiling of patient-derived organoids

2024-12-29

Abstract excerpt

Patient-derived organoids (PDOs) are poised to become central tools both in clinical practice, to preemptively identify patient optimal treatments, and in drug discovery, overcoming the limitations of cancer cell lines. However, the use of PDOs in these settings has been hampered by several bottlenecks, including sample requirements, assay time, and handling in the context of high-throughput assays. We developed a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: db3f4893-0148-5650-8760-d587ebf7fe6e
DOI: 10.1101/2024.12.28.630600

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A high-throughput 3D culture microfluidic platform for multi-parameter phenotypic and omics profiling of patient-derived organoidsDOI 10.1101/2024.12.28.630600Read

Precision Oncology at a Crossroads: How Organoid Platforms Are Reshaping the FieldSemantic proximity Read

Whole-Process 3D ECM-Encapsulated Organoid-Based Automated High-Throughput Screening Platform Accelerates Drug Discovery for Rare DiseasesSemantic proximity Read

Impact of non-genetic heterogeneity of BRAF-mutant colon cancer organoids on growth kinetics, drug sensitivity and Wnt dynamics.Semantic proximity Read

Comparative characterization of OncoPro™ and Wnt-Based media reveals distinct phenotypic and pharmacologic states in patient-derived tumor organoidsSemantic proximity Read

The drug-induced phenotypic landscape of colorectal cancer organoidsSemantic proximity Read

The drug-induced phenotypic landscape of colorectal cancer organoids.Semantic proximity Read

Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screeningSemantic proximity Read

Development of an automated 3D high content cell screening platform for organoid phenotyping.Semantic proximity Read

In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screeningSemantic proximity Read

A 3D microtumour system that faithfully represents ovarian cancer minimal residual diseaseSemantic proximity Read

Breaking the mold: 3D cell cultures reshaping the future of cancer researchSemantic proximity Read

An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissuesSemantic proximity Read